{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:14:30Z","timestamp":1789143270462,"version":"build-2803163510"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jprasurg.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bjps.2026.08.002","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:29:03Z","timestamp":1786033743000},"page":"139-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Peri-operative CDK4\/6 inhibitors in DIEP flap breast reconstruction: Early safety data and proposed management strategy"],"prefix":"10.1016","volume":"121","author":[{"given":"O.","family":"Sharp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.M.L.","family":"Battisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.W.D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bjps.2026.08.002_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.annonc.2025.10.005","article-title":"Overall survival with abemaciclib in early breast cancer","volume":"37","author":"Johnston","year":"2026","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bjps.2026.08.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104683","article-title":"How should we manage abemaciclib in the peri-operative period during secondary breast reconstruction: balancing oncologic benefit and surgical safety","volume":"85","author":"Cazenave","year":"2026","journal-title":"Breast"},{"key":"10.1016\/j.bjps.2026.08.002_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102827","article-title":"Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation","volume":"130","author":"Hua","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bjps.2026.08.002_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111330","article-title":"ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4\/6, HER2, PARP, or mTOR inhibitors","volume":"215","author":"van Aken","year":"2026","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.bjps.2026.08.002_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/curroncol32030154","article-title":"Perioperative drug management of systemic therapies in breast cancer: a literature review and treatment recommendations","volume":"32","author":"Galuia","year":"2025","journal-title":"Curr Oncol"}],"container-title":["Journal of Plastic, Reconstructive & Aesthetic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681526004456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1748681526004456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:01:20Z","timestamp":1789142480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1748681526004456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":5,"alternative-id":["S1748681526004456"],"URL":"https:\/\/doi.org\/10.1016\/j.bjps.2026.08.002","relation":{},"ISSN":["1748-6815"],"issn-type":[{"value":"1748-6815","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peri-operative CDK4\/6 inhibitors in DIEP flap breast reconstruction: Early safety data and proposed management strategy","name":"articletitle","label":"Article Title"},{"value":"Journal of Plastic, Reconstructive & Aesthetic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjps.2026.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}